Strategies and options for minimizing resistance emergence in pulmonary infections

被引：6

作者：

Amyes, SGB ^{[1
]}

机构：

[1] Univ Edinburgh, Sch Med, Dept Med Microbiol, Edinburgh EH8 9AG, Midlothian, Scotland

来源：

CHEST | 1998年 / 113卷 / 03期

关键词：

D O I：

10.1378/chest.113.3_Supplement.228S

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

The early-onset hospital pulmonary Gram-negative infections may respond to eiprofloxacin and co-amoxiclav without significant resistance development. Penicillin-resistant Streptococcus pneumoniae may be treated with macrolides, fluoroquinolones, and glycoyeptides. The late-onset hospital pathogens all seem to have developed resistance to cephalosporins, so greater reliance is now made on the fluoroquinolones and carbapenems when aminoglycoside therapy is considered undesirable.

引用

页码：228S / 232S

页数：5

共 26 条

[11] ACTIVITY OF TEICOPLANIN AND VANCOMYCIN AGAINST PENICILLIN-RESISTANT PNEUMOCOCCI [J].

KLUGMAN, KP .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 (01) :1-2

[12] PREVALENCE OF FLUOROQUINOLONE RESISTANCE IN EUROPE [J].

KRESKEN, M ;

HAFNER, D ;

MITTERMAYER, H ;

VERBIST, L ;

BERGOGNEBEREZIN, E ;

GIAMARELLOU, H ;

ESPOSITO, S ;

VANKLINGEREN, B ;

KAYSER, FH ;

REEVES, DS ;

WIEDEMANN, B ;

ROTTER, M ;

WEWALKA, G ;

AICHINGER, W ;

BREITFELLNER, G ;

SCHINDLER, J ;

STRATCHUNSKY, L ;

LAUWERS, S ;

OSTERRIETH, P ;

VERSCHRAEGEN, G ;

VANLANDYT, H ;

MERTENS, A ;

KARTLEVEN, J ;

POTVLIEGHE, C ;

FUSSLE, R ;

LUTTICKEN, R ;

HOPKEN, MS ;

FABRICIUS, K ;

WERNER, H ;

ULLMANN, U ;

NICULESCU, ER ;

LANGMAACK, H ;

RINGELMANN, R ;

MACHKA, K ;

OPFERKUCH, W ;

DASCHNER, F ;

MANNHEIM, W ;

WAGNER, J ;

ROHR, HP ;

SCHAFER, V ;

WITTE, W ;

KELLER, P ;

NAUMANN, G ;

HUOVINEN, P ;

AVRIL, P ;

BEBEAR, P ;

DABERNAT, H ;

DRUGEON, P ;

DUVAL, P ;

FLEURETTE, P .

INFECTION, 1994, 22 :S90-S98

[13] DECREASED SUSCEPTIBILITY OF PENICILLIN-RESISTANT PNEUMOCOCCI TO 24-BETA-LACTAM ANTIBIOTICS [J].

LINARES, J ;

ALONSO, T ;

PEREZ, JL ;

AYATS, J ;

DOMINGUEZ, MA ;

PALLARES, R ;

MARTIN, R .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 (03) :279-288

[14]

NOBLE WC, 1992, FEMS MICROBIOL LETT, V93, P195

[15] NOVEL PLASMID-MEDIATED BETA-LACTAMASE (MIR-1) CONFERRING RESISTANCE TO OXYIMINO-LACTAMS AND ALPHA-METHOXY BETA-LACTAMS IN CLINICAL ISOLATES OF KLEBSIELLA-PNEUMONIAE [J].

PAPANICOLAOU, GA ;

MEDEIROS, AA ;

JACOBY, GA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (11) :2200-2209

[16]

PERCIVAL A, 1977, LANCET, V2, P1175

[17] Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta-lactamase: Parallel outbreaks due to multiple plasmid transfer [J].

Prodinger, WM ;

Fille, M ;

Bauernfeind, A ;

Stemplinger, I ;

Amann, S ;

Pfausler, B ;

LassFlorl, C ;

Dierich, MP .

JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (03) :564-568

[18] EFFECT OF BETA-LACTAMASE EXPRESSION ON SUSCEPTIBILITY OF LOCAL ISOLATES OF ENTEROBACTER-CLOACAE, SERRATIA-MARCESCENS AND PSEUDOMONAS-AERUGINOSA TO BETA-LACTAM ANTIBIOTICS [J].

RAMADAN, MA ;

TAWFIK, AF ;

SHIBL, AM .

CHEMOTHERAPY, 1995, 41 (03) :193-199

[19] TRANSFERABLE IMIPENEM-RESISTANCE IN ACINETOBACTER SPECIES FROM A CLINICAL SOURCE [J].

SCAIFE, W ;

YOUNG, HK ;

PATON, RH ;

AMYES, SGB .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (03) :585-586

[20] Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems [J].

Senda, K ;

Arakawa, Y ;

Nakashima, K ;

Ito, H ;

Ichiyama, S ;

Shimokata, K ;

Kato, N ;

Ohta, M .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) :349-353

← 1 2 3 →